Literature DB >> 12119560

Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.

Taichi Kanamaru1, Ken-Ichi Tanaka, Joji Kotani, Kimihiko Ueno, Masahiro Yamamoto, Yuka Idei, Hisashi Hisatomi, Yoshifumi Takeyama.   

Abstract

Telomerase activity and hTERT mRNA expression are upregulated in colorectal cancer. Whether they are inherent in colorectal adenomas, premalignant lesions to cancer, however, remains to be elucidated. We examined telomerase activity by the fluorescence-based telomeric repeat amplification protocol method and analyzed the level of hTERT mRNA by real-time polymerase chain reaction in 74 surgically obtained neoplasms from 29 patients. The specimens were divided into 6 categories according to the criteria of the Vienna Classification. The control comprising 29 non-pathological mucosa were classified into category 1, 6 adenomas indefinite for neoplasia into category 2, 21 non-invasive low grade adenomas into category 3, 23 high grade adenomas or non-invasive carcinomas into category 4, and 15 intramucosal or submucosal carcinomas into category 5. Carcinoma invading beyond the submucosa (9 samples) was referentially subdivided into category 6. Telomerase activity (mean +/- standard error) in 1 categories to 6 were 5.0+/-1.2, 1.8+/-1.7, 4.3+/-1.6, 20.2+/-2.1, 36.4+/-5.5, and 55.5+/-8.2 units/microg protein, respectively. There were no statistical differences between categories 1 and 2, 1 and 3, and 2 and 3. A significant statistical difference in the other two was observed by the multiple comparison test. The mean levels of hTERT mRNA was 103.1+/-102.4, 103.6+/-103.0, 103.6+/-102.9, 103.7+/-102.9, 104.0+/-103.4, and 104.4+/-104.0 copies/microg total RNA, respectively. There was a significant statistical difference only between category 6 and each of the other categories. These results suggest that telomerase activation occurs during the progression from low-grade to high-grade dysplasia in adenomas and increases steadily with the progression of the degree of dysplasia and invasion during colorectal carcinogenesis, and that hTERT mRNA expression is a feature of the late stage development of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119560

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study.

Authors:  Reza Yadegarazari; Taghi Hassanzadeh; Amir Majlesi; Amir Keshvari; Alireza Monsef Esfahani; Amirsasan Tootoonchi; Nooshin Shabab; Massoud Saidijam
Journal:  Iran Biomed J       Date:  2013

2.  The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.

Authors:  María José Safont; Mireia Gil; Rafael Sirera; Eloísa Jantus-Lewintre; Elena Sanmartín; Sandra Gallach; Cristina Caballero; Nieves Del Pozo; Eugenio Palomares; Carlos Camps
Journal:  Clin Transl Oncol       Date:  2011-06       Impact factor: 3.405

3.  Morphologic and molecular events at the invading edge of colorectal carcinomas.

Authors:  Carlos A Rubio
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

4.  The biological relevance of laminin 5gamma2 expression at the invading edge of colonic carcinomas.

Authors:  Clase Lenander; Carlos A Rubio
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  Telomerase activity in chronic inflammatory bowel disease.

Authors:  Elke Kleideiter; Ulrike Friedrich; Alexandra Möhring; Siegfried Walker; Emil Höring; Karlernst Maier; Peter Fritz; Klaus-Peter Thon; Ulrich Klotz
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

6.  Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin.

Authors:  Kjetil Søreide; Einar Gudlaugsson; Ivar Skaland; Emiel A M Janssen; Bianca Van Diermen; Hartwig Körner; Jan P A Baak
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

7.  Evaluation of the Expression of the Inhibitor of Apoptosis Protein Family and Human Telomerase Reverse Transcriptase in Patients With Advanced Colorectal Adenoma.

Authors:  Joon Young Choi; Hyuk Yoon; Gyeongjae Na; Yoon Jin Choi; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee
Journal:  J Cancer Prev       Date:  2017-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.